Consolidated net sales for the first quarter were 31,454 million yen (Year-over-Year +2.0%); operating income was 141 million yen (Year-over-Year -45.5%); net income attributable to owners of parent for the quarter was 36 million yen (Year-over-Year -77.9%). This was the first quarter following the integration with DVx, with the deemed acquisition date set at 2026-09-30 and new subsidiaries included in the consolidation scope. The full-year earnings forecast has been revised and disclosed separately.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2689","jir_company_name":"OLBA DVx HEALTHCARE, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-30","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/2689-20261030-01.pdf","jir_short_summary":"Consolidated net sales for the first quarter were 31,454 million yen (Year-over-Year +2.0%); operating income was 141 million yen (Year-over-Year -45.5%); net income attributable to owners of parent for the quarter was 36 million yen (Year-over-Year -77.9%). This was the first quarter following the integration with DVx, with the deemed acquisition date set at 2026-09-30 and new subsidiaries included in the consolidation scope. The full-year earnings forecast has been revised and disclosed separately.","jir_summary":"### Business Overview\nThis quarter was the initial phase following the business integration with DVx Co., Ltd. Consolidated net sales were 31,454 million yen (Year-over-Year +2.0%). However, due to integration-related expenses and investments in personnel and DX, operating income was 141 million yen (Year-over-Year -45.5%), and net income attributable to owners of parent for the quarter was 36 million yen (Year-over-Year -77.9%). The consolidated scope newly includes Sogo Medical Services Co., Ltd., and goodwill of 1,560,005 thousand yen was recorded.\n\n### Outlook and Strategy\nThe company aims to expand sales channels and improve logistics and DX efficiency through synergies from the integration. While one-off expenses such as DX promotion costs are affecting results amid structural changes in the medical device market, the full-year forecast has been published separately. By segment, measures to increase sales will continue in medical devices, SPD and caregiving products. Emphasis will be placed on building a long-term growth platform through new headquarters relocation, workforce strengthening, and IT investments.","jir_financial_highlights":"Net Sales: 31,454 (Year-over-Year +2.0%)\nOperating Income: 141 (Year-over-Year -45.5%)\nOrdinary Income: 122 (Year-over-Year -52.2%)\nNet Income Attributable to Owners of Parent (Quarter): 36 (Year-over-Year -77.9%)\nTotal Assets: 74,152 (Increase from previous fiscal year)\nEquity Ratio: 28.1% (0.1 percentage point increase from previous fiscal year)","jir_category":"","jir_hashtags":"#OLBADVxHEALTHCARE_Inc. Release, #Earnings, #QuarterlyResults","jir_key_figures":"Net Sales: 31,454 million yen (Year-over-Year +2.0%)\nOperating Income: 141 million yen (Year-over-Year -45.5%)\nNet Income Attributable to Owners of Parent (Quarter): 36 million yen (Year-over-Year -77.9%)","jir_meta_title":"OLBA DVx HEALTHCARE, Inc. First Quarter Financial Summary | Net Sales 31,454 million yen, Net Income 36 million yen","jir_meta_description":"A summary of OLBA DVx HEALTHCARE, Inc.'s first quarter financial results. Net sales increased 2.0% year-over-year while operating profit declined significantly. Explains impacts of the recent integration and outlines growth strategies. Includes an overview of results and segment trends.","jir_og_title":"OLBA DVx HEALTHCARE, Inc. First Quarter Financial Summary","jir_og_description":"An overview of the initial quarter following the new integration. Sales were steady but operating profit declined. Attention focused on growth strategies and expected synergy realization.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":58611,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-138836","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n